Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Atea Pharmaceuticals Inc (NASDAQ: AVIR) closed the day trading at $3.71 down -6.31% from the previous closing price of $3.96. In other words, the price has decreased by -$6.31 from its previous closing price. On the day, 0.73 million shares were traded. AVIR stock price reached its highest trading level at $3.92 during the session, while it also had its lowest trading level at $3.645.
Ratios:
For a better understanding of AVIR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.28 and its Current Ratio is at 13.28. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On January 06, 2022, Morgan Stanley Downgraded its rating to Underweight which previously was Equal-Weight and also lowered its target price recommendation from $14 to $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 01 ’24 when Sommadossi Jean-Pierre sold 56,910 shares for $3.85 per share. The transaction valued at 218,819 led to the insider holds 116,557 shares of the business.
Horga Maria Arantxa sold 15,870 shares of AVIR for $60,963 on Feb 01 ’24. The Chief Medical Officer now owns 25,664 shares after completing the transaction at $3.84 per share. On Feb 01 ’24, another insider, Corcoran Andrea, who serves as the insider of the company, sold 15,843 shares for $3.84 each. As a result, the insider received 60,915 and left with 670,208 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVIR now has a Market Capitalization of 312467712 and an Enterprise Value of -226809296.
Stock Price History:
The Beta on a monthly basis for AVIR is 0.22, which has changed by 0.033426166 over the last 52 weeks, in comparison to a change of 0.2644323 over the same period for the S&P500. Over the past 52 weeks, AVIR has reached a high of $5.19, while it has fallen to a 52-week low of $2.77. The 50-Day Moving Average of the stock is -4.34%, while the 200-Day Moving Average is calculated to be 6.40%.
Shares Statistics:
Over the past 3-months, AVIR traded about 308.53K shares per day on average, while over the past 10 days, AVIR traded about 244270 shares per day. A total of 83.44M shares are outstanding, with a floating share count of 73.93M. Insiders hold about 12.22% of the company’s shares, while institutions hold 64.61% stake in the company. Shares short for AVIR as of 1714435200 were 1798410 with a Short Ratio of 5.83, compared to 1711584000 on 1666331. Therefore, it implies a Short% of Shares Outstanding of 1798410 and a Short% of Float of 3.0.
